{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T14:57:48Z","timestamp":1794236268921,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/02789-7"],"award-info":[{"award-number":["2021\/02789-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/24524-7"],"award-info":[{"award-number":["2016\/24524-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115074","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T10:54:37Z","timestamp":1672484077000},"page":"115074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Identification of inhibitors as drug candidates against Chagas disease"],"prefix":"10.1016","volume":"248","author":[{"given":"Sheila Cruz","family":"Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Molina","family":"de Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Alves","family":"Costa-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Gustavo","family":"Tempone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Henrique Ghilardi","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-0676","authenticated-orcid":false,"given":"Kathia Maria","family":"Honorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115074_bib1","unstructured":"Chagas disease, (n.d.). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis) (accessed June 17, 2022)."},{"key":"10.1016\/j.ejmech.2022.115074_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14787210.2019.1577731","article-title":"Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America","volume":"17","author":"Alonso-Padilla","year":"2019","journal-title":"Exp. Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2022.115074_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115074_bib4","first-page":"63","article-title":"An Update on the knowledge of parasite\u2013vector interactions of Chagas Disease","volume":"12","author":"Schaub","year":"2021","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.ejmech.2022.115074_bib5","series-title":"Doen\u00e7a de Chagas","year":"2017"},{"key":"10.1016\/j.ejmech.2022.115074_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5334\/gh.484","article-title":"WHF, IASC roadmap on Chagas disease","volume":"15","author":"E Echeverr\u00eda","year":"2020","journal-title":"Global Heart"},{"key":"10.1016\/j.ejmech.2022.115074_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2174\/156802662017200624115305","article-title":"World Chagas disease day and the new road map for neglected tropical diseases","volume":"20","author":"Ferreira","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas Disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ejmech.2022.115074_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1107\/S2053230X19006320","article-title":"Cruzain structures: apocruzain and cruzain bound to S -methyl thiomethanesulfonate and implications for drug design","volume":"75","author":"Barbosa da Silva","year":"2019","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Commun."},{"key":"10.1016\/j.ejmech.2022.115074_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fchem.2019.00798","article-title":"Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi, Activity","volume":"7","author":"Ferreira","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib11","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/ijms20071742","article-title":"Structure-based virtual screening and in vitro evaluation of new Trypanosoma cruzi cruzain inhibitors","volume":"20","author":"Herrera-Mayorga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.115074_bib12","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760210385","article-title":"Computational approaches towards the discovery and optimisation of cruzain inhibitors","volume":"117","author":"Santos","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2022.115074_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97490-2","article-title":"The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites","volume":"11","author":"Santos","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.115074_bib14","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","article-title":"Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acs.jcim.9b00802","article-title":"Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach","volume":"60","author":"de Souza","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.115074_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3762\/bjoc.9.3","article-title":"Chemical\u2013biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target","volume":"9","author":"Choy","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/EC.00341-13","article-title":"Trypanosoma cruzi bromodomain factor 3 binds acetylated \u03b1-tubulin and concentrates in the flagellum during metacyclogenesis","volume":"13","author":"Alonso","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2022.115074_bib18","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1021\/acsinfecdis.0c00618","article-title":"Fragment-based identification of ligands for bromodomain-containing factor 3 of Trypanosoma cruzi","volume":"7","author":"Laurin","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115074_bib19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acsinfecdis.2c00057","article-title":"Essential bromodomain Tc BDF2 as a drug target against Chagas disease","volume":"8","author":"Pezza","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115074_bib20","doi-asserted-by":"crossref","first-page":"e00047","DOI":"10.1128\/MMBR.00047-16","article-title":"Bromodomains in Protozoan Parasites: evolution, function, and opportunities for drug development","volume":"81","author":"Jeffers","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2022.115074_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2018.08.016","article-title":"Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer","volume":"437","author":"Dalal","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2022.115074_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/prot.20149","article-title":"Comparative evaluation of eight docking tools for docking and virtual screening accuracy","volume":"57","author":"Kellenberger","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2022.115074_bib23","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesne","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1002139","article-title":"The Trypanosoma cruzi protease cruzain mediates immune evasion","volume":"7","author":"Doyle","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2022.115074_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115074_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Exp. Op. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115074_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.115074_bib28","article-title":"Essential oils from different Myrtaceae species from Brazilian Atlantic Forest biome - chemical dereplication and evaluation of antitrypanosomal activity","volume":"19","author":"Maiolini","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2022.115074_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/acs.jnatprod.0c01303","article-title":"Antitrypanosomal lactones from Nectandra barbellata","volume":"84","author":"Londero","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.115074_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002370","article-title":"Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay","volume":"7","author":"Wiggers","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115074_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/molecules22061015","article-title":"Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: virtual screening, in vitro and in vivo studies","volume":"22","author":"Palos","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115074_bib32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/ijms20071742","article-title":"Structure-based virtual screening and in vitro evaluation of new Trypanosoma cruzi cruzain inhibitors","volume":"20","author":"Herrera-Mayorga","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200976X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200976X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:02:40Z","timestamp":1777528960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200976X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"alternative-id":["S022352342200976X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115074","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of inhibitors as drug candidates against Chagas disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115074"}}